Search - tctmd.com

Displaying 1 - 20 of 23

Sort: Relevancy | Date

Video

» Interview

Beyond the Data: COMPARE-TAVI 1

May 22, 2025

Video

» Interview

Beyond the Data: Cardiac Damage in Asymptomatic Severe Aortic Stenosis

May 21, 2025

Video

» Interview

Beyond the Data: The ALIGN-AR Trial

April 18, 2025

Video

» Interview

Beyond the Data: PROTECT-TAVI

March 29, 2025

Video

» Interview

Treatment of AS in Young Patients

June 24, 2024

Video

» Interview

Preemptive (Early) TAVI in Severe and Moderate AS Patients

June 24, 2024

Video

» Interview

Introducing Target AS

June 24, 2024

Video

» Interview

Bicuspid Aortic Valve Controversies: The Next Steps

June 24, 2024

Video

» Interview

Advances in the Management of AR

June 24, 2024

Video

» Interview

Beyond the Data: The WATCH-TAVR Trial

October 25, 2023

Video

» Interview

Beyond the Data: Aortic Stenosis in the Frail Patient

October 25, 2023

Video

» Interview

Beyond the Data: Removing Barriers in Structural Heart Care

October 25, 2023

Video

» Interview

Cardiac Damage and Quality of Life After Aortic Valve Replacement: Results from the PARTNER Trials

September 21, 2022

Video

» Interview

Three-Year Outcomes of the Randomized SCOPE I Trial Comparing the ACURATE Neo Versus the SAPIEN 3 Transcatheter Heart Valve System in Patients With Symptomatic Severe Aortic Stenosis

September 18, 2022

Video

» Interview

Pathology of Self-Expanding Transcatheter Aortic Valve Failure and Hypo-Attenuated Leaflet Thickening (HALT)

September 17, 2022

Video

» Interview

A Randomized ADAPT-TAVR Trial: Edoxaban Versus Dual Antiplatelet Therapy for Valve Thrombosis and Cerebral Thromboembolism After Transcatheter Aortic-Valve Replacement

May 4, 2022

Video

» Interview

ACC 2022: Insights from the CoreValve US Pivotal and SURTAVI Trials: Five-Year Incidence, Timing And Predictors of Hemodynamic Valve Deterioration ff Transcatheter snd Surgical Aortic Bioprostheses

April 3, 2022

Video

» Interview

Apixaban After TAVI for Aortic Stenosis: ATLANTIS

May 20, 2021

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Vinod Thourani About PARTNER 2A: 5-Year Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

September 28, 2019

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Jonas Lanz About SCOPE I: A Randomized Trial of the ACURATE Neo vs. the SAPIEN 3 Bioprosthesis in Patients With Severe Aortic Stenosis

September 26, 2019

Advertisement

Beyond the Data: COMPARE-TAVI 1

Beyond the Data: Cardiac Damage in Asymptomatic Severe Aortic Stenosis

Beyond the Data: The ALIGN-AR Trial

Beyond the Data: PROTECT-TAVI

Treatment of AS in Young Patients

Preemptive (Early) TAVI in Severe and Moderate AS Patients

Introducing Target AS

Bicuspid Aortic Valve Controversies: The Next Steps

Advances in the Management of AR

Beyond the Data: The WATCH-TAVR Trial

Beyond the Data: Aortic Stenosis in the Frail Patient

Beyond the Data: Removing Barriers in Structural Heart Care

Cardiac Damage and Quality of Life After Aortic Valve Replacement: Results from the PARTNER Trials

Three-Year Outcomes of the Randomized SCOPE I Trial Comparing the ACURATE Neo Versus the SAPIEN 3 Transcatheter Heart Valve System in Patients With Symptomatic Severe Aortic Stenosis

Pathology of Self-Expanding Transcatheter Aortic Valve Failure and Hypo-Attenuated Leaflet Thickening (HALT)

A Randomized ADAPT-TAVR Trial: Edoxaban Versus Dual Antiplatelet Therapy for Valve Thrombosis and Cerebral Thromboembolism After Transcatheter Aortic-Valve Replacement

ACC 2022: Insights from the CoreValve US Pivotal and SURTAVI Trials: Five-Year Incidence, Timing And Predictors of Hemodynamic Valve Deterioration ff Transcatheter snd Surgical Aortic Bioprostheses

Apixaban After TAVI for Aortic Stenosis: ATLANTIS

Dr. C. Michael Gibson Talks With Dr. Vinod Thourani About PARTNER 2A: 5-Year Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

Dr. C. Michael Gibson Talks With Dr. Jonas Lanz About SCOPE I: A Randomized Trial of the ACURATE Neo vs. the SAPIEN 3 Bioprosthesis in Patients With Severe Aortic Stenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content